New hope for Drug-Resistant herpes in vulnerable patients
Disease control
Completed
This study tested a new oral drug called pritelivir against standard treatments (foscarnet, cidofovir, or imiquimod) for herpes infections that no longer respond to acyclovir. It involved 158 immunocompromised participants, such as those with HIV or organ transplants. The goal wa…
Phase: PHASE3 • Sponsor: AiCuris Anti-infective Cures AG • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC